Vaia Florou

1.5k total citations · 1 hit paper
56 papers, 822 citations indexed

About

Vaia Florou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Vaia Florou has authored 56 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Vaia Florou's work include Cancer Genomics and Diagnostics (16 papers), Sarcoma Diagnosis and Treatment (14 papers) and Pancreatic and Hepatic Oncology Research (13 papers). Vaia Florou is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Sarcoma Diagnosis and Treatment (14 papers) and Pancreatic and Hepatic Oncology Research (13 papers). Vaia Florou collaborates with scholars based in United States, Austria and Spain. Vaia Florou's co-authors include Breelyn A. Wilky, Jonathan C. Trent, Despina S. Kolonias, Andrew E. Rosenberg, Eric Wieder, Krishna V. Komanduri, Ignacio Garrido‐Laguna, Wungki Park, Darcy A. Kerr and Ty K. Subhawong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Vaia Florou

50 papers receiving 820 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial

2019 260 citations Breelyn A. Wilky, Vaia Florou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vaia Florou United States	11	655	512	218	120	106	56	822
Veridiana Pires de Camargo Brazil	9	539 0.8×	641 1.3×	207 0.9×	167 1.4×	66 0.6×	26	878
Nadia Hindi Spain	16	445 0.7×	667 1.3×	162 0.7×	126 1.1×	120 1.1×	81	889
U. Matulonis United States	9	342 0.5×	252 0.5×	80 0.4×	93 0.8×	57 0.5×	33	596
Ravin Ratan United States	14	240 0.4×	368 0.7×	85 0.4×	129 1.1×	55 0.5×	54	563
Nicholas Papadopolous United States	10	499 0.8×	643 1.3×	211 1.0×	136 1.1×	128 1.2×	11	1.0k
Samer Salah Jordan	14	323 0.5×	491 1.0×	69 0.3×	57 0.5×	189 1.8×	59	726
Elena Conca Italy	16	341 0.5×	808 1.6×	110 0.5×	138 1.1×	131 1.2×	38	1.1k
Heike Loeser Germany	17	280 0.4×	274 0.5×	65 0.3×	70 0.6×	266 2.5×	30	731
Mihaela Druta United States	14	252 0.4×	255 0.5×	65 0.3×	56 0.5×	41 0.4×	43	437
Xin Sun China	13	281 0.4×	451 0.9×	44 0.2×	70 0.6×	105 1.0×	63	706

Countries citing papers authored by Vaia Florou

Since Specialization

Citations

This map shows the geographic impact of Vaia Florou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vaia Florou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vaia Florou more than expected).

Fields of papers citing papers by Vaia Florou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vaia Florou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vaia Florou. The network helps show where Vaia Florou may publish in the future.

Co-authorship network of co-authors of Vaia Florou

This figure shows the co-authorship network connecting the top 25 collaborators of Vaia Florou. A scholar is included among the top collaborators of Vaia Florou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vaia Florou. Vaia Florou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaw, Matthew, et al.. (2025). KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma. JAMA Network Open. 8(1). e2453588–e2453588. 8 indexed citations

Groisberg, Roman, Andrew Elliott, Don S. Dizon, et al.. (2025). Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma. Clinical Cancer Research. 31(11). 2210–2221.

Nevala-Plagemann, Chris, et al.. (2025). Gemcitabine-induced myositis in a patient with pancreatic cancer. BMJ Case Reports. 18(1). e259660–e259660. 1 indexed citations

Florou, Vaia, Michelle F. Jacobs, Ruth Casey, et al.. (2025). A Review of Genomic Testing and SDH‐ Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST. Cancer Medicine. 14(3). e70669–e70669.

Heumann, Thatcher, Mark Yarchoan, Jiayun Lu, et al.. (2024). A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer.. Journal of Clinical Oncology. 42(16_suppl). 4017–4017. 3 indexed citations

Faber, Erik B., Peter J. Hosein, Anthony F. Shields, et al.. (2024). Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets. JCO Precision Oncology. 8(8). e2300595–e2300595. 3 indexed citations

Boland, Patrick M., Heinz‐Josef Lenz, Kristen K. Ciombor, et al.. (2024). A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer. Investigational New Drugs. 43(1). 60–68. 2 indexed citations

Jayakrishnan, Thejus, Yasmine Baca, Joanne Xiu, et al.. (2024). Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers. JCO Precision Oncology. 8(8). e2400138–e2400138. 3 indexed citations

Florou, Vaia, et al.. (2024). 689TiP A phase I/IIa trial of Aurora-A inhibitor (JAB-2485) in adult patients with advanced solid tumors. Annals of Oncology. 35. S533–S534. 1 indexed citations

10.

Florou, Vaia, Andrew Elliott, Matthew H. Bailey, et al.. (2023). Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC. Clinical Cancer Research. 29(17). 3408–3417. 10 indexed citations

11.

Florou, Vaia, Charalampos S. Floudas, Asaf Maoz, et al.. (2023). Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden. Journal for ImmunoTherapy of Cancer. 11(8). e007440–e007440. 9 indexed citations

12.

Florou, Vaia, et al.. (2023). Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma: case report. Journal of Gastrointestinal Oncology. 14(6). 2637–2643. 1 indexed citations

13.

Greenberg, Samantha, Wendy Kohlmann, Joanne Jeter, et al.. (2022). Discrepancies between tumor genomic profiling and germline genetic testing. ESMO Open. 7(4). 100526–100526. 10 indexed citations

14.

Florou, Vaia & Ignacio Garrido‐Laguna. (2022). Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer. Current Oncology Reports. 24(9). 1107–1112. 20 indexed citations

15.

Florou, Vaia & Breelyn A. Wilky. (2022). Emerging mechanisms of immunotherapy resistance in sarcomas. Cancer Drug Resistance. 5(1). 199–213. 5 indexed citations

16.

Florou, Vaia & Breelyn A. Wilky. (2021). Current Management of Angiosarcoma: Recent Advances and Lessons From the Past. Current Treatment Options in Oncology. 22(7). 61–61. 28 indexed citations

17.

Gray, Jhanelle E., et al.. (2021). Biomarkers of therapeutic response with immune checkpoint inhibitors. Annals of Translational Medicine. 9(12). 1040–1040. 3 indexed citations

18.

Florou, Vaia, Sonam Puri, Ignacio Garrido‐Laguna, & Breelyn A. Wilky. (2021). Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction. Annals of Translational Medicine. 9(12). 1035–1035. 11 indexed citations

19.

Florou, Vaia, Elke A. Jarboe, & Georgios Deftereos. (2020). Intravenous Leiomyomatosis: A Rare Diagnosis With Aggressive Potential. JCO Oncology Practice. 17(4). 206–208. 3 indexed citations

20.

Florou, Vaia, Andrew E. Rosenberg, Eric Wieder, et al.. (2019). Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. Journal for ImmunoTherapy of Cancer. 7(1). 213–213. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact